Spinal Non-Fusion Market

According to a survey by GlobalData, degenerative spinal disorders will drive the expansion of the North American artificial disc replacement (ADR) market from $274.6 million in 2016 to $614.5 million by 2023, indicating a compound annual growth rate (CAGR) of 12.2%.
The primary elements influencing the industry's expansion related to degenerative spinal disorders among the aging population are identified in the research. The benefits of ADR devices over conventional spinal fusion techniques, such as mobility preservation, are fueling the expansion.
The most popular spinal non-fusion operation worldwide is cervical disc replacement. According to Jennifer Ryan, a healthcare analyst at GlobalData, more recent developments in clinical effectiveness and improved reimbursement situations have facilitated the introduction of ADR systems. Growth in the worldwide spinal non-fusion market is anticipated to be fueled by the approval of cervical systems for use in multi-level indications.
Despite the remarkable rise seen by the cervical ADR system, Ryan continues, lumbar ADR systems have not been able to experience a growth comparable to that of cervical ADR systems because there is insufficient clinical effectiveness data and because the method is complicated.
Large multinational corporations that are well-established in the orthopaedic and spine businesses dominate the worldwide ADR market. DePuy Synthes, Medtronic, among others
There are a lot of small- and medium-sized businesses functioning in the market. The analysis anticipates a rise in mergers and acquisitions as major multinational corporations seek to diversify their product portfolios.
To gain more information on the spinal non-fusion market forecast, download a free report sample

read more..